Abstract: Compound of formula (I):
wherein:
n is 0 or 1,
W represents —CO— or S(O)q and q is 0, 1 or 2,
G represents a G1, G2, G3 or G4 group as defined in the description,
Z represents alkyl, aryl, heteroaryl, arylalkyl, arylalkenyl, arylalkynyl, heteroarylalkenyl, heteroarylalkynyl or heteroarylalkyl each optionally substituted.
Type:
Grant
Filed:
April 14, 2000
Date of Patent:
June 12, 2001
Assignee:
Adir et Compagnie
Inventors:
Jean-Luc Fauchere, Jean-Claude Ortuno, Jacques Duhault, Jean Albert Boutin, Nigel Levens
Abstract: Sample displacement chromatography is performed at low operating pressures (less than 30 bar) and/or at high sample loading (in excess of 500 mg/cm2 column area), with product recovery being effected in a non-gradient manner. The low operating pressures permit the use of simple and inexpensive apparatus. Non-gradient product recovery allows the desired product to be allowed in solutions with advantageously high concentration. Materials which may be purified include pharmaceuticals, pharmaceutical excipients, fine chemicals, biochemicals, X-ray contrast agents, chelating agents, peptides, proteins, oligonucleotides and vaccines. Apparatus embodiments include sample displacement chromatography apparatus comprising one or more ion exchange columns in direct combination with one or more desalting columns, and multicolumn chromatography apparatus permitting switching between a series separation mode and a parallel extraction mode.
Abstract: A water-dispersible lipidic hop extract composition, comprising at least 10% by weight of free fatty acid substances derived from hops, is useful to increase the utilization of the hop aroma and flavor components. It may be produced by treatment of an extract of hops with an excess of alkali. The starting hop extract, made conventionally as by extraction with organic solvent or carbon dioxide, preferably has alpha, isoalpha, and beta hop acids removed before treatment with excess alkali. A cosolvent, such as a lower alkanol, polyol, or wetting agent, heat, or high shear may be used to improve mixing of the lipidic organic phase of the hop extract with the excess alkali. The water-dispersible lipidic hop extract imparts an enhanced hop aroma and flavor upon addition to the wort at some point during the brewing process between boiling and the beginning of fermentation. A beer incorporating the dispersible lipidic hop extract has a stronger hop aroma and flavor than beer incorporating the usual hop extract.
Abstract: The invention relates to compounds of general formula (I):
in which R, R1, R2, X and Y are as defined in the description, their geometrical and/or optical isomers, and their addition salts with a pharmaceutically-acceptable acid or base, as well as to medicaments containing the same.
Type:
Grant
Filed:
June 4, 1999
Date of Patent:
May 15, 2001
Assignee:
Adir et Compagnie
Inventors:
Christian Marazano, Delphine Compere, Bhupesh Chandra Das, Jean Lepagnol
Abstract: The present invention relates to a process for the preparation of high-grade chloramine by the action of commercial eau de Javelle of 100 chlorometric degrees on a solution of ammonia in the presence of ammonium chloride. According to this process, the chloramine is obtained having a content greater than or equal to 2 mol L−1, that is to say, greater than or equal to 10.3%. The process can be carried out continuously or discontinuously.
Abstract: The invention concerns multilayer microspheres containing an acid substance, a basic substance, and a water-soluble isolating agent which, when it dissolves in water, after almost instant effervescence, brings about a homogeneous dispersion of active principal(s) which is present in the acid and basic substances. The invention also concerns a method for preparing such microspheres by rotational granulation on a fluid air bed associated with a system of tangential spraying of the wetting liquid.
Abstract: A thermoplastic ionomer blend or alloy exhibiting advantageous properties upon molding or extrusion and/or thermoforming, consisting essentially of the following components:
A. about 15 to 85 parts by weight of a thermoplastic copolymer containing about 91 to 80 weight percent of alpha-olefin units and about 9 to 20 weight percent of alpha, beta-ethylenically unsaturated carboxylic acid units said carboxylic acid units being about 20 to 90 percent neutralized with metal ions, preferably zinc,
B. about 10 to 80 parts by weight of a rubber, preferably a thermoplastic elastomer selected from the group consisting of (a) crosslinked ethylene-propylene-diene copolymers and equivalent polyolefin copolymers such as ethylene-butene, hexene, or octene, (b) acrylonitrile-butadiene copolymers, (c) styrene-butadiene copolymers, and (d) styrene acrylonitrile graft-crosslinked butadiene rubbers, and
C.
Type:
Grant
Filed:
March 18, 1999
Date of Patent:
March 27, 2001
Assignee:
A. Schulman, Inc.
Inventors:
Dennis C. Smith, Anita Shah, Alain C. Adam, Roy H. Kinsey, Brian D. Fairchild
Abstract:
The invention concerns novel cyclohexane derivatives difunctionalised in 1.4 of general formula (1) in which A represents a group such as (IIa) in which Ar itself represents an aromatic structure such as phenyl or pyrimidinyl optionally substituted by one or several groups such as C1-C3 alkyl, C1-C3 alkoxy, trifluoromethyl or halogen (IIb); B represents a heterocyclic group such as: 3,5-dioxo-(2H,4H)-1,2,4 triazine substituted in position 2 (IIIa); 3-oxo-(2H)-1,2,4 triazine substituted in position 5 (IIIb); 3,5-dioxo-6-amino-(2H,4H)-1,2,4-triazine (IIIc) in which R represents a C1-C3 alkyl group. The invention also concerns the salts of compounds of general formula I with pharmaceutically acceptable acids. It also concerns the various “cis” and “trans” isomers and the various enantiomers with asymmetric carbons.
Type:
Grant
Filed:
April 14, 2000
Date of Patent:
February 20, 2001
Assignee:
Pierre Fabre Medicament
Inventors:
Jean-François Patoiseau, Elisabeth Dupont-Passelaigue, Wouter Koek
Abstract: A method for repairing a defect in cartilage, comprising the provision of apertures in the cartilage by drilling holes at the base of the cartilage defect, which holes may enter the mesenchymal depot, introducing a porous scaffold material containing a plurality of magnetic particles into the apertures, and subsequently and sequentially injecting magnetically-tagged cartilage growth promoting materials such as various growth factors or chondrocytes into the area of the defect. The magnetically tagged growth promoting material is then drawn into the apertures by magnetic attraction of the magnetic particles contained in the porous scaffold material, either by virtue of the particles being permanently magnetic, or by the imposition of an external magnetic field. The present application claims the biodegradable porous scaffold material containing the plurality of magnetic particles.
Abstract: The invention relates to a compound of formula (I):
wherein:
A represents an optionally substituted benzene ring,
B represents an imidazoline ring of formula (Ia) or (Ib):
and medicinal products containing the same/are useful in treating or in preventing depression, obesity, panic attacks, anxiety, obsessive-compulsive disorders, cognitive disorders, phobias, impulsive disorders associated with the abuse of drugs and withdrawal therefrom, sexual dysfunctions, and Parkinson's disease.
Type:
Grant
Filed:
December 17, 1999
Date of Patent:
January 9, 2001
Assignee:
Adir et Compagnie
Inventors:
Alex Cordi, Mark Millan, Adrian Newman-Tancredi, Mauricette Brocco
Abstract: Compounds of formula (I):
R—NH—A—CO—NH—NH—(W)n—Z (I)
wherein:
n is 0 or 1,
W represents —CO— or S(O)r wherein r is 0, 1 or 2,
Z represents a group selected from aryl, arylalkyl, heteroaryl and heteroarylalkyl, each optionally substituted,
R represents a grouping selected from:
Z1—T—CO—, Z1—O—T—CO—, Z1—T—O—CO—, Z1—T—S(O)q—
wherein Z1, T and q are as defined in the description,
A represents alkylene, alkenylene or alkynylene each having from 3 to 8 carbon atoms, alkylenecycloalkylene, cycloalkylenealkylene, alkylenecycloalkylenealkylene, alkylenearylene, arylenealkylene, alkylenearylenealkylene a grouping
wherein
B1 is as defined in the description, or A forms with the adjacent nitrogen atom a grouping
as defined in the description, and
medicinal products containing the same which are useful as Neuropeptide Y receptor
Type:
Grant
Filed:
December 16, 1999
Date of Patent:
January 9, 2001
Assignee:
Adir et Compagnie
Inventors:
Antonio Monge Vega, Ignacio Aldana Moraza, Daniel-Henri Caignard, Jacques Duhault, Jean Boutin, Odile Dellazuana
Abstract: A compound of formula (I): ##STR1## wherein: R.sub.1, R.sub.2 and R.sub.3, which may be the same or different, represent a group as defined in the description,R.sub.4 represents hydrogen, alky, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl, arylalkyl, heterocycloalkyl, heterocycloalkylalkyl, heteroaryl, or heteroarylalkyl,R.sub.5 represents aryl, or heteroaryl, each optionally substituted,n is an integer from 1 to 3 inclusive,their isomers and addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal products containing the same are usefull in the treatment of disease like depression, panic attacks, obsessive-compulsive disorders, phobias, impulsive disorders, drug abuse or anxiety.
Type:
Grant
Filed:
March 23, 2000
Date of Patent:
November 28, 2000
Assignee:
Adir et Compagnie
Inventors:
Jean-Louis Peglion, Bertrand Goument, Aimee Dessinges, Mark Millan, Jean-Michel Rivet, Anne Dekeyne
Abstract: A compound of formula (I): ##STR1## wherein Ra represents linear or branched (C.sub.1 -C.sub.8)alkylene,Rb represents single bond, or linear or branched (C.sub.1 -C.sub.6)alkylene,Z represents thiocarbamate, or thioamide, each being optionally substituted,T represents optionally substituted morpholino,its isomers, and pharmaceutically-acceptable acid or base addition salts thereof, and medicinal products containing the same which are useful in the treatment of disease for which the use of anti-oxidation agent is required.
Type:
Grant
Filed:
December 14, 1999
Date of Patent:
November 21, 2000
Assignee:
Adir et Compagnie
Inventors:
Solo Goldstein, Claude Guillonneau, Yves Charton, Pierre Lestage, Brian Lockhart